Global Targeted RNA Sequencing Market By Type (Enrichment Approaches, And Amplicon-Based Approaches), By Application (Research Institutes, Hospitals & Clinics, Biotechnology Company, And Diagnostic Lab), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 137522
- 18-Dec
- PDF/PPT/Word
-
Report Details
The report on Targeted RNA Sequencing Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. forecast years. The global targeted rna sequencing market is segmented on the basis of Type, Application, and geography.
The Global Targeted RNA Sequencing market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.
Targeted RNA Sequencing Market Scope:
By type, the market is segmented into enrichment approaches, and amplicon-based approaches. By Application, the market is divided into Research Institutes, Hospitals & Clinics, Biotechnology Company, and Diagnostic Lab.
Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Thermo Fisher, Illumina, Roche Holding AG, BGI, Eurofins, LabCorp, Berry Genomics, Macrogen, and GENEWIZ.Key Market Segments
Type
enrichment approaches
amplicon-based approaches
Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Key Market Players included in the report:
Thermo Fisher
Illumina
Roche Holding AG
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Targeted RNA Sequencing Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Targeted RNA Sequencing Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Targeted RNA Sequencing Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Targeted RNA Sequencing Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Targeted RNA Sequencing Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Targeted RNA Sequencing Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Targeted RNA Sequencing sub-markets, depending on key regions (various vital states).
To analyze Targeted RNA Sequencing Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Targeted RNA Sequencing Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
Primary worldwide Targeted RNA Sequencing Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Targeted RNA Sequencing Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Targeted RNA Sequencing Market Overview3.1. Targeted RNA Sequencing Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges 3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Targeted RNA Sequencing Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Targeted RNA Sequencing Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. enrichment approaches4.4. amplicon-based approaches5. Global Targeted RNA Sequencing Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Targeted RNA Sequencing Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Research Institutes5.4. Hospitals & Clinics
5.5. Biotechnology Company
5.6. Diagnostic Lab6. Global Targeted RNA Sequencing Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Targeted RNA Sequencing Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Targeted RNA Sequencing Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Targeted RNA Sequencing Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Targeted RNA Sequencing Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Targeted RNA Sequencing Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Targeted RNA Sequencing Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Thermo Fisher7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments 7.4. Illumina7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments 7.5. Roche Holding AG7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments 7.6. BGI7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments 7.7. Eurofins7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments 7.8. LabCorp7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments 7.9. Berry Genomics7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments 7.10. Macrogen7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments 7.11. GENEWIZ7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
